Stanford PIPRA Validation Study in an Elderly Orthopedic Population (PIPRA-ORTHO)

August 20, 2024 updated by: Jose R Maldonado, MD, Stanford University

Stanford Study of the Validation of the Pre-Interventional Preventive Risk Assessment (PIPRA) Tool In The At-Risk Orthopedic Surgery Population

The purpose of this study is to determine the accuracy of an AI-based tool in the prediction of postoperative delirium (POD), in a population at moderately high risk of developing this syndrome (i.e., elderly orthopedic subjects). The population to be studied has already been enrolled in a parallel study regarding the likelihood of developing delirium, its relationship to the type of anesthetic, and the relationship between anesthetic type, development of delirium and risk for post-operative cognitive impairment (including risk for dementia) (Protocol ID#55169 [David Drover-Principal investigator; José Maldonado-Co-investigator]).

Study Overview

Detailed Description

Study investigators would like to determine the real-life accuracy of a new tool developed for the prediction of delirium: Pre-Interventional Preventive Risk Assessment (PIPRA) Tool. The importance of assessing the risk for post-operative delirium (POD) includes: providing clinicians and patients with accurate predictive information regarding the patient's risk for developing delirium as part of the risk/benefit calculation for surgical procedures, and thus potential risk of subsequent cognitive impairment; as well as the ability to introduce timely prophylactic techniques that may prevent its onset.

The PIPRA tools consists of nine items commonly found in any presurgical patient's electronic medical record (EMR). The tool has been designed to run in the background of the EMR and automatically calculate the patient's risk for developing delirium upon admission for surgical intervention. For our study, we will be applying the PIPRA tool to the EMR of patients already enrolled in a parallel study as detailed above.

The PIPRA tool predicts the risk of developing POD delirium based on its algorithm that takes into consideration the following nine clinical variables: age, height/weight or body mass index, the American Society of Anesthesiologist physical status Classification system (ASA), past history of delirium, past history of cognitive impairment (including dementia), number of medications, preoperative C-reactive protein levels, surgical risk (as determined by the European Society of Anesthesiology), and type of surgery. The subsequent result predicts the risk (in percentage) of a patient developing POD following surgery.

The PIPRA tool is fully integrated into EMR systems, operating in the background, extracting relevant information, and automatically generating a delirium prediction score. In addition, this software possesses the flexibility to recalibrate the delirium risk based on the availability of the nine clinical variables.

Study Type

Observational

Enrollment (Actual)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Stanford Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Stanford Hospital geriatric patients having surgery

Description

Inclusion Criteria:

  • Surgical patients
  • Greater than or equal to 65 years old
  • ASA I, II or III
  • Greater than 90 min of surgery
  • Non-cardiac surgery

Exclusion Criteria:

  • Dementia
  • Alzheimer's
  • Parkinson's
  • Current Benzodiazepine use
  • Alcoholism
  • Previous surgery within the last 12 months or expected in the 12 months to come (except the expected surgery for which they are being enrolled).
  • Color-blindness

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of subjects with postoperative delirium accurately predicted by the PIPRA Tool
Time Frame: Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
Assessment of the accuracy on the prediction of subjects identified as developing delirium by the PIPRA tool, as compared with post-operative standardized delirium assessment tools. We will compare the assessment of the PIPRA prediction tool (performed pre-op) with the actual development of delirium as assessed by a clinical assessment based on DSM; the CAM-ICU & SPTD assessment tools.
Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
Development of post-operative Delirium
Time Frame: Up to 72 hours post-operatively
Number of subjects diagnosed with post-operative delirium
Up to 72 hours post-operatively
Determination of Delirium Phenotype
Time Frame: Up to 72 hours post-operatively.
For those who develop delirium, the phenotype of delirium will be determined as per the Liptzin-Levkoff Criteria (based on DSM diagnostic Criteria). As such, all delirium episodes will be categorized as: hyperactive, hypoactive, mixed, or subsyndromal delirium.
Up to 72 hours post-operatively.
Impact of delirium on post-operative cognitive impairment
Time Frame: Up to 10-year post-operatively.
Impact of delirium occurrence and emergence of cognitive impairment post-operatively
Up to 10-year post-operatively.
Sensitivity and specificity of the PIPRA tool for detecting postoperative delirium.
Time Frame: Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
Sensitivity and specificity of various cut off points of the PIPRA tool for detecting postoperative delirium.
Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
Receiver operating characteristic (ROC) curve analysis of PIPRA tool
Time Frame: Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
Receiver operating characteristic (ROC) curve analysis of PIPRA tool
Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Discharge Site
Time Frame: Type of facility the patient was discharge to from the hospital (assessed up to 6 months from admission)
Site of discharge (e.g., home, rehabilitation, skilled nurse facility, etc)
Type of facility the patient was discharge to from the hospital (assessed up to 6 months from admission)
Requirement of Intensive Care Unit Admission
Time Frame: Time to discharge from the hospital (assessed up to 6 months from admission)
Need for admission to an intensive care unit due to clinical necessity or deterioration
Time to discharge from the hospital (assessed up to 6 months from admission)
Immediate Postoperative Mortality
Time Frame: From date of post-operative admission up to time of postoperative discharge, an average of 72 hours.
Mortality rate immediately after index surgery
From date of post-operative admission up to time of postoperative discharge, an average of 72 hours.
Length of Hospital Length of Stay
Time Frame: From date of post-operative admission up to time of postoperative discharge (assessed up to 1 year after admission).
Total number of days admitted to the hospital
From date of post-operative admission up to time of postoperative discharge (assessed up to 1 year after admission).
Need of pharmacological protocol
Time Frame: From post-operative hospital admission up to time of postoperative discharge (assessed up to 6 months from admission)
Need of pharmacological protocol for management of delirium
From post-operative hospital admission up to time of postoperative discharge (assessed up to 6 months from admission)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: José R Maldonado, MD, Stanford University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2024

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

August 20, 2024

First Submitted That Met QC Criteria

August 20, 2024

First Posted (Actual)

August 22, 2024

Study Record Updates

Last Update Posted (Actual)

August 22, 2024

Last Update Submitted That Met QC Criteria

August 20, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Subscribe